METHOD OF PRODUCING MULTIPOTENT STEM CELLS
    21.
    发明申请
    METHOD OF PRODUCING MULTIPOTENT STEM CELLS 审中-公开
    生产多种干细胞的方法

    公开(公告)号:US20150322405A1

    公开(公告)日:2015-11-12

    申请号:US14364200

    申请日:2012-12-13

    摘要: The present invention provides a method of producing a multipotent stem cell, said method comprising culturing at least one fibroblast cell in the presence of an effective amount of at least one small molecule reprogramming factor(s) that induces the cell to de-differentiate into a multipotent stem cell, wherein the method excludes the use of reprogramming factor(s) that are not small molecules. The small molecule reprogramming factor(s) may include a G9a HMTase inhibitor(s) and/or a MEK inhibitor(s) optionally in combination with other small molecule reprogramming factor(s). The invention also includes methods of differentiating the multipotent stem cells, cells produced by the methods, assays using the cells and kits for use in the methods.

    摘要翻译: 本发明提供了一种产生多能干细胞的方法,所述方法包括在存在有效量的至少一种小分子重编程因子的情况下培养至少一种成纤维细胞,所述小分子重编程因子诱导细胞脱分化为 多能干细胞,其中该方法不包括使用不是小分子的重编程因子。 小分子重编程因子可以包括任选与其它小分子重编程因子组合的G9a HMTase抑制剂和/或MEK抑制剂。 本发明还包括区分多能干细胞,通过该方法产生的细胞,使用细胞的测定法和用于该方法的试剂盒的方法。

    METHOD FOR ENHANCING EMBRYO IMPLANTATION

    公开(公告)号:US20210213053A1

    公开(公告)日:2021-07-15

    申请号:US17059221

    申请日:2019-05-29

    摘要: A method of enhancing embryo implantation in a subject is disclosed which comprises administering to the uterine cavity of the subject a formulation comprising copper and/or zinc in an amount effective to stimulate endometrial production of leukaemia inhibitory factor (LIF) and/or vascular endothelial growth factor (VEGF). Alternatively, a device may be inserted into the uterine cavity of the subject, wherein the device comprises copper and/or zinc, for a period of time that is effective to stimulate endometrial production of LIF and/or VEGF. The method is suitable for use with women undergoing treatment by any of the assisted reproductive technologies, such as those involving the transfer of embryos such as in vitro fertilisation (IVF) and variants including IVF-ICSI (intracytoplasmic sperm injection) and in vitro maturation (IVM) treatments, as well as intrauterine-insemination (IUI) therapy. However, the method is also applicable for women wanting to improve their prospects of pregnancy through natural conception.